Latest Moderna (NASDAQ:MRNA) News

Page 1

Page 1 of 1

Moderna raises outlook as melanoma data adds fresh growth potential

Moderna lifts 2026 outlook as quarterly profit returns and melanoma data advances

Moderna returned to quarterly GAAP profit, raised its 2026 revenue growth outlook and reported positive Phase 3 melanoma data. The stronger quarter was supported by international COVID vaccine sales, while cash generation and pipeline execution remain important tests.

Ada Torres

6 Nov 2026